Waters (WAT) Q1 Earnings and Revenues Beat Estimates

Core Insights - Waters (WAT) reported quarterly earnings of $2.25 per share, exceeding the Zacks Consensus Estimate of $2.22 per share, and showing a slight increase from $2.21 per share a year ago, resulting in an earnings surprise of 1.35% [1] - The company achieved revenues of $661.71 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.08% and reflecting a year-over-year increase from $636.84 million [2] - Waters has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The future performance of Waters' stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's price movement based on recent earnings and future expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $2.93, with projected revenues of $737.31 million, and for the current fiscal year, the consensus EPS is $12.84 on revenues of $3.08 billion [7] Industry Context - The Medical - Instruments industry, to which Waters belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked using tools like the Zacks Rank [5][6]